Clinicopathologic and molecular features associated with patient age in gastric cancer

World Journal of Gastroenterology

Volumn 21, Issue 22, 2015, Pages 6905-6913

  Seo, Ji Yeon ^a   Jin, Eun Hyo ^b   Jo, Hyun Jin ^b   Yoon, Hyuk ^c   Shin, Cheol Min ^c   Park, Young Soo ^c   Kim, Nayoung ^c   Jung, Hyun Chae ^c   Lee, Dong Ho ^c  

^a Seoul National University College of Medicine   (South Korea)

^b Seoul National University College of Medicine   (South Korea)

^c Seoul National University Bundang Hospital   (South Korea)

Author keywords

Age; Gastric cancer; Microsatellite instability; Molecular pathology; Prognosis; Stage

Indexed keywords

ANTINEOPLASTIC AGENT; CA 19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; DNA; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; PROTEIN P53; ERBB2 PROTEIN, HUMAN; TP53 PROTEIN, HUMAN; TUMOR MARKER;

ADULT; ADVANCED CANCER; AGE; ARTICLE; ATROPHIC GASTRITIS; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER PALLIATIVE THERAPY; CANCER PATIENT; CANCER PROGNOSIS; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CANCER TISSUE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA EXTRACTION; FEMALE; GENE OVEREXPRESSION; GROUPS BY AGE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTESTINE METAPLASIA; MAJOR CLINICAL STUDY; MALE; MICROSATELLITE INSTABILITY; MOLECULAR PATHOLOGY; MULTIMODALITY CANCER THERAPY; OVERALL SURVIVAL; POLYMERASE CHAIN REACTION; PRECANCER; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; SENESCENCE; SOUTH KOREA; STOMACH CANCER; TISSUE SECTION; UNIVERSITY HOSPITAL; CHEMISTRY; COMPARATIVE STUDY; DISEASE FREE SURVIVAL; GENETICS; KAPLAN MEIER METHOD; MIDDLE AGED; MOLECULAR DIAGNOSIS; MORTALITY; PATHOLOGY; PREDICTIVE VALUE; RISK FACTOR; STOMACH NEOPLASMS; TIME FACTOR; COHORT ANALYSIS; DISEASE ACTIVITY; DNA ISOLATION; GASTRECTOMY; HUMAN CELL;

ADULT; AGE FACTORS; BIOMARKERS, TUMOR; DISEASE-FREE SURVIVAL; FEMALE; HOSPITALS, UNIVERSITY; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; MALE; MICROSATELLITE INSTABILITY; MIDDLE AGED; MOLECULAR DIAGNOSTIC TECHNIQUES; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; RECEPTOR, ERBB-2; REPUBLIC OF KOREA; RETROSPECTIVE STUDIES; RISK FACTORS; STOMACH NEOPLASMS; TIME FACTORS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84930848124     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v21.i22.6905     Document Type: Article

References (28)

1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin 2013; 63: 11-30 [PMID: 23335087 DOI: 10.3322/ caac.21166]
2. Jemal A, Center MM, DeSantis C, Ward EM. Global patterns of cancer incidence and mortality rates and trends. Cancer Epidemiol Biomarkers Prev 2010; 19: 1893-1907 [PMID: 20647400 DOI: 10.1158/1055-9965.EPI-10-0437]
3. Wu CW, Tsay SH, Hsieh MC, Lo SS, Lui WY, P'eng FK. Clinicopathological significance of intestinal and diffuse types of gastric carcinoma in Taiwan Chinese. J Gastroenterol Hepatol 1996; 11: 1083-1088 [PMID: 8985835]
4. Theuer CP, de Virgilio C, Keese G, French S, Arnell T, Tolmos J, Klein S, Powers W, Oh T, Stabile BE. Gastric adenocarcinoma in patients 40 years of age or younger. Am J Surg 1996; 172: 473-46; discussion 473-46; [PMID: 8942547 DOI: 10.1016/ S0002-9610(96)00223-1]
5. Kath R, Fiehler J, Schneider CP, Höffken K. Gastric cancer in very young adults: apropos four patients and a review of the literature. J Cancer Res Clin Oncol 2000; 126: 233-237 [PMID: 10782897]
6. Park JC, Lee YC, Kim JH, Kim YJ, Lee SK, Hyung WJ, Noh SH, Kim CB. Clinicopathological aspects and prognostic value with respect to age: an analysis of 3,362 consecutive gastric cancer patients. J Surg Oncol 2009; 99: 395-401 [PMID: 19347884 DOI: 10.1002/jso.21281]
7. Hsieh FJ, Wang YC, Hsu JT, Liu KH, Yeh CN. Clinicopathological features and prognostic factors of gastric cancer patients aged 40 years or younger. J Surg Oncol 2012; 105: 304-309 [PMID: 22116742 DOI: 10.1002/jso.22084]
8. Kulig J, Popiela T, Kolodziejczyk P, Sierzega M, Jedrys J, Szczepanik AM. Clinicopathological profile and long-term outcome in young adults with gastric cancer: multicenter evaluation of 214 patients. Langenbecks Arch Surg 2008; 393: 37-43 [PMID: 17618451 DOI: 10.1007/s00423-007-0208-z]
9. Moreira H, Pinto-de-Sousa J, Carneiro F, Cardoso de Oliveira M, Pimenta A. Early onset gastric cancer no longer presents as an advanced disease with ominous prognosis. Dig Surg 2009; 26: 215-221 [PMID: 19468231 DOI: 10.1159/000219331]
10. Eguchi T, Takahashi Y, Yamagata M, Kasahara M, Fujii M. Gastric cancer in young patients. J Am Coll Surg 1999; 188: 22-26 [PMID: 9915238]
11. Smith BR, Stabile BE. Extreme aggressiveness and lethality of gastric adenocarcinoma in the very young. Arch Surg 2009; 144: 506-510 [PMID: 19528381]
12. The Paris endoscopic classification of superficial neoplastic lesions: esophagus, stomach, and colon: November 30 to December 1, 2002. Gastrointest Endosc 2003; 58: S3-43 [PMID: 14652541]
13. Kajitani T. The general rules for the gastric cancer study in surgery and pathology. Part I. Clinical classification. Jpn J Surg 1981; 11: 127-139 [PMID: 7300058]
14. Washington K. 7th edition of the AJCC cancer staging manual: stomach. Ann Surg Oncol 2010; 17: 3077-3079 [PMID: 20882416 DOI: 10.1245/s10434-010-1362-z]
15. lauren P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histoclinical classification. Acta Pathol Microbiol Scand 1965; 64: 31-49 [PMID: 14320675]
16. Stolte M, Meining A. The updated Sydney system: classification and grading of gastritis as the basis of diagnosis and treatment. Can J Gastroenterol 2001; 15: 591-598 [PMID: 11573102]
17. Wu MS, Lee CW, Shun CT, Wang HP, Lee WJ, Chang MC, Sheu JC, Lin JT. Distinct clinicopathologic and genetic profiles in sporadic gastric cancer with different mutator phenotypes. Genes Chromosomes Cancer 2000; 27: 403-411 [PMID: 10719371]
18. Choi JS, Kim MA, Lee HE, Lee HS, Kim WH. Mucinous gastric carcinomas: clinicopathologic and molecular analyses. Cancer 2009; 115: 3581-3590 [PMID: 19479974 DOI: 10.1002/cncr.24422]
19. Seo YH, Joo YE, Choi SK, Rew JS, Park CS, Kim SJ. Prognostic significance of p21 and p53 expression in gastric cancer. Korean J Intern Med 2003; 18: 98-103 [PMID: 12872447]
20. Kim JY, Shin NR, Kim A, Lee HJ, Park WY, Kim JY, Lee CH, Huh GY, Park do Y. Microsatellite instability status in gastric cancer: a reappraisal of its clinical significance and relationship with mucin phenotypes. Korean J Pathol 2013; 47: 28-35 [PMID: 23483099 DOI: 10.4132/KoreanJPathol.2013.47.1.28]
21. Pounder RE, Ng D. The prevalence of Helicobacter pylori infection in different countries. Aliment Pharmacol Ther 1995; 9 Suppl 2: 33-39 [PMID: 8547526]
22. Correa P, Haenszel W, Cuello C, Tannenbaum S, Archer M. A model for gastric cancer epidemiology. Lancet 1975; 2: 58-60 [PMID: 49653]
23. El-Zimaity HMT O, Kim JG, Akamatsu T, Gürer IE, Simjee AE, Graham DY. Geographic differences in the distribution of intestinal metaplasia in duodenal ulcer patients. Am J Gastroenterol 2001; 96: 666-672 [PMID: 11280531 DOI: 10.1111/ j.1572-0241.2001.03601.x]
24. Chen C, Yang JM, Hu TT, Xu TJ, Yan G, Hu SL, Wei W, Xu WP. Prognostic role of human epidermal growth factor receptor in gastric cancer: a systematic review and meta-analysis. Arch Med Res 2013; 44: 380-389 [PMID: 23871709 DOI: 10.1016/j.arcmed.2013.07.001]
25. Terashima M, Kitada K, Ochiai A, Ichikawa W, Kurahashi I, Sakuramoto S, Katai H, Sano T, Imamura H, Sasako M. Impact of expression of human epidermal growth factor receptors EGFR and ERBB2 on survival in stage II/III gastric cancer. Clin Cancer Res 2012; 18: 5992-6000 [PMID: 22977193 DOI: 10.1158/1078-0432. CCR-12-1318]
26. Lasithiotakis K, Antoniou SA, Antoniou GA, Kaklamanos I, Zoras O. Gastrectomy for stage IV gastric cancer. a systematic review and meta-analysis. Anticancer Res 2014; 34: 2079-2085 [PMID: 24778009]
27. Sun J, Song Y, Wang Z, Chen X, Gao P, Xu Y, Zhou B, Xu H. Clinical significance of palliative gastrectomy on the survival of patients with incurable advanced gastric cancer: a systematic review and meta-analysis. BMC Cancer 2013; 13: 577 [PMID: 24304886 DOI: 10.1186/1471-2407-13-577]
28. Hofmann M, Stoss O, Shi D, Büttner R, van de Vijver M, Kim W, Ochiai A, Rüschoff J, Henkel T. Assessment of a HER2 scoring system for gastric cancer: results from a validation study. Histopathology 2008; 52: 797-805 [PMID: 18422971 DOI: 10.1111/ j.1365-2559.2008.03028.x]